AI assistant
Skye Bioscience, Inc. — Director's Dealing 2020
Aug 14, 2020
34097_dirs_2020-08-13_efedec83-4b69-451c-84e2-9c86bcd58ebf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Emerald Bioscience, Inc. (EMBI)
CIK: 0001516551
Period of Report: 2020-08-07-05:00
Reporting Person: Emerald Health Sciences Inc. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-07-05:00 | Common Stock | S | 2566666 | $0.1 | Disposed | 123923501 | Direct |
Footnotes
F1: The original Form 4, filed on August 11, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 7, 2020, as a total of 3,000,000 shares sold when in fact 2,566,6660 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an addition in the number of shares reported as beneficially owned by the reporting person by 433,334 shares.